KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBITDA: 2009-2024

Historic EBITDA for Thermo Fisher Scientific (TMO) over the last 16 years, with Dec 2024 value amounting to $7.3 billion.

  • Thermo Fisher Scientific's EBITDA rose 5.60% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 4.63%. This contributed to the annual value of $7.3 billion for FY2024, which is 6.97% up from last year.
  • According to the latest figures from FY2024, Thermo Fisher Scientific's EBITDA is $7.3 billion, which was up 6.97% from $6.9 billion recorded in FY2023.
  • In the past 5 years, Thermo Fisher Scientific's EBITDA ranged from a high of $10.0 billion in FY2021 and a low of $6.9 billion during FY2023.
  • Moreover, its 3-year median value for EBITDA was $7.3 billion (2024), whereas its average is $7.5 billion.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 69.66% in 2020, then dropped by 18.28% in 2023.
  • Thermo Fisher Scientific's EBITDA (Yearly) stood at $7.8 billion in 2020, then rose by 28.66% to $10.0 billion in 2021, then declined by 16.30% to $8.4 billion in 2022, then fell by 18.28% to $6.9 billion in 2023, then climbed by 6.97% to $7.3 billion in 2024.